Determinants of cholesterol efflux capacity in humans

Wilson, 1988, High density lipoprotein cholesterol and mortality, The Framingham Heart Study Arteriosclerosis, 8, 737

Barter, 2003, High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions, Atherosclerosis, 168, 195, 10.1016/S0021-9150(03)00006-6

Choi, 2006, The role of high-density lipoprotein cholesterol in the prevention and possible treatment of cardiovascular diseases, Curr Mol Med, 6, 571, 10.2174/156652406778018590

Rader, 2014, HDL and cardiovascular disease, Lancet, 384, 618, 10.1016/S0140-6736(14)61217-4

Tall, 2008, Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins, J Intern Med, 263, 256, 10.1111/j.1365-2796.2007.01898.x

Khera, 2011, Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis, N Engl J Med, 364, 127, 10.1056/NEJMoa1001689

Saleheen, 2015, Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study, Lancet Diabetes Endocrinol, 3, 507, 10.1016/S2213-8587(15)00126-6

Ritsch, 2015, HDL cholesterol efflux capacity and cardiovascular events, N Engl J Med, 372, 1870

Cuchel, 2006, Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?, Circulation, 113, 2548, 10.1161/CIRCULATIONAHA.104.475715

Seo, 2015, Cholesterol homeostasis in cardiovascular disease and recent advances in measuring cholesterol signatures, J Steroid Biochem Mol Biol, 153, 72, 10.1016/j.jsbmb.2015.04.014

Camont, 2011, Biological activities of HDL subpopulations and their relevance to cardiovascular disease, Trends Mol Med, 17, 594, 10.1016/j.molmed.2011.05.013

Yamashita, 2010, Molecular mechanisms of HDL-cholesterol elevation by statins and its effects on HDL functions, J Atheroscler Thromb, 17, 436, 10.5551/jat.5405

Rader, 2009, The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis, J Lipid Res, 50, S189, 10.1194/jlr.R800088-JLR200

Rye, 1999, Remodelling of high density lipoproteins by plasma factors, Atherosclerosis, 145, 227, 10.1016/S0021-9150(99)00150-1

van der Velde, 2008, Regulation of direct transintestinal cholesterol excretion in mice, Am J Physiol Gastrointest Liver Physiol, 295, G203, 10.1152/ajpgi.90231.2008

Temel, 2010, A new framework for reverse cholesterol transport: non-biliary contributions to reverse cholesterol transport, World J Gastroenterol, 16, 5946

Vrins, 2012, Trans-intestinal cholesterol efflux is not mediated through high density lipoprotein, J Lipid Res, 53, 2017, 10.1194/jlr.M022194

de la Llera-Moya, 2010, The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages, Arterioscler Thromb Vasc Biol, 30, 796, 10.1161/ATVBAHA.109.199158

Aiello, 2003, ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation, Arterioscler Thromb Vasc Biol, 23, 972, 10.1161/01.ATV.0000054661.21499.FB

Hafiane, 2015, High density lipoproteins: measurement techniques and potential biomarkers of cardiovascular risk, BBA Clin, 3, 175, 10.1016/j.bbacli.2015.01.005

Brown, 2013, Cholesterol efflux analyses using stable isotopes and mass spectrometry, Anal Biochem, 433, 56, 10.1016/j.ab.2012.10.007

Sankaranarayanan, 2011, A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol, J Lipid Res, 52, 2332, 10.1194/jlr.D018051

Zhang, 2011, Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol, Assay Drug Dev Technol, 9, 136, 10.1089/adt.2010.0288

Robinet, 2010, A simple and sensitive enzymatic method for cholesterol quantification in macrophages and foam cells, J Lipid Res, 51, 3364, 10.1194/jlr.D007336

Holleboom, 2013, In vivo tissue cholesterol efflux is reduced in carriers of a mutation in APOA1, J Lipid Res, 54, 1964, 10.1194/jlr.P028449

Turner, 2012, Measurement of reverse cholesterol transport pathways in humans: in vivo rates of free cholesterol efflux, esterification, and excretion, J Am Heart Assoc, 1, 10.1161/JAHA.112.001826

Cuchel, 2017, A novel approach to measuring macrophage-specific reverse cholesterol transport in vivo in humans, J Lipid Res, 58, 752, 10.1194/jlr.M075226

Low, 2012, Cholesterol efflux assay, J Vis Exp, 61

Li, 2013, Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks, Arterioscler Thromb Vasc Biol, 33, 1696, 10.1161/ATVBAHA.113.301373

Wang, 2007, Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo, J Clin Invest, 117, 2216, 10.1172/JCI32057

Larrede, 2009, Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent, Arterioscler Thromb Vasc Biol, 29, 1930, 10.1161/ATVBAHA.109.194548

Naik, 2006, Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo, Circulation, 113, 90, 10.1161/CIRCULATIONAHA.105.560177

Bortnick, 2000, The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines, J Biol Chem, 275, 28634, 10.1074/jbc.M003407200

Santamarina-Fojo, 2001, Regulation and intracellular trafficking of the ABCA1 transporter, J Lipid Res, 42, 1339, 10.1016/S0022-2275(20)30266-2

Kilsdonk, 1995, Cellular cholesterol efflux mediated by cyclodextrins, J Biol Chem, 270, 17250, 10.1074/jbc.270.29.17250

Zidovetzki, 2007, Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies, Biochim Biophys Acta, 1768, 1311, 10.1016/j.bbamem.2007.03.026

Adorni, 2007, The roles of different pathways in the release of cholesterol from macrophages, J Lipid Res, 48, 2453, 10.1194/jlr.M700274-JLR200

Trigueros-Motos, 2017, ABCA8 regulates cholesterol efflux and high-density lipoprotein cholesterol levels, Arterioscler Thromb Vasc Biol, 37, 2147, 10.1161/ATVBAHA.117.309574

Sankaranarayanan, 2013, Serum albumin acts as a shuttle to enhance cholesterol efflux from cells, J Lipid Res, 54, 671, 10.1194/jlr.M031336

Pamir, 2017, Plasminogen promotes cholesterol efflux by the ABCA1 pathway, JCI Insight, 2, 10.1172/jci.insight.92176

Hafiane, 2017, ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesis, Atherosclerosis, 257, 90, 10.1016/j.atherosclerosis.2017.01.013

Davidson, 2016, The effects of apolipoprotein B depletion on HDL subspecies composition and function, J Lipid Res, 57, 674, 10.1194/jlr.M066613

Kingwell, 2014, HDL-targeted therapies: progress, failures and future, Nat Rev Drug Discov, 13, 445, 10.1038/nrd4279

Di Bartolo, 2016, Clinical trials with cholesteryl ester transfer protein inhibitors, Curr Opin Lipidol, 27, 545, 10.1097/MOL.0000000000000352

Bowman, 2017, Effects of Anacetrapib in patients with atherosclerotic vascular disease, N Engl J Med, 377, 1217, 10.1056/NEJMoa1706444

Kontush, 2013, Unraveling the complexities of the HDL lipidome, J Lipid Res, 54, 2950, 10.1194/jlr.R036095

Asztalos, 2011, Metabolic and functional relevance of HDL subspecies, Curr Opin Lipidol, 22, 176, 10.1097/MOL.0b013e3283468061

Krauss, 2010, Lipoprotein subfractions and cardiovascular disease risk, Curr Opin Lipidol, 21, 305, 10.1097/MOL.0b013e32833b7756

Camont, 2013, Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities, Arterioscler Thromb Vasc Biol, 33, 2715, 10.1161/ATVBAHA.113.301468

Lund-Katz, 2013, Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein, J Biol Chem, 288, 23150, 10.1074/jbc.M113.495523

Gulshan, 2013, Sphingomyelin depletion impairs anionic phospholipid inward translocation and induces cholesterol efflux, J Biol Chem, 288, 37166, 10.1074/jbc.M113.512244

Darabi, 2016, Can phosphatidylserine enhance atheroprotective activities of high-density lipoprotein?, Biochimie, 120, 81, 10.1016/j.biochi.2015.06.022

Du, 2015, HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export, Circ Res, 116, 1133, 10.1161/CIRCRESAHA.116.305485

Agarwala, 2015, High-Density Lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease, Arterioscler Thromb Vasc Biol, 35, 1515, 10.1161/ATVBAHA.115.305504

Kontush, 2015, HDL particle number and size as predictors of cardiovascular disease, Front Pharmacol, 6, 218, 10.3389/fphar.2015.00218

Arsenault, 2009, HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study, Atherosclerosis, 206, 276, 10.1016/j.atherosclerosis.2009.01.044

Favari, 2009, Small discoidal pre-beta1 HDL particles are efficient acceptors of cell cholesterol via ABCA1 and ABCG1, Biochemistry, 48, 11067, 10.1021/bi901564g

Ray, 2014, The effect of cholesteryl ester transfer protein inhibition on lipids, lipoproteins, and markers of HDL function after an acute coronary syndrome: the dal-ACUTE randomized trial, Eur Heart J, 35, 1792, 10.1093/eurheartj/ehu105

Yvan-Charvet, 2010, Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib, Arterioscler Thromb Vasc Biol, 30, 1430, 10.1161/ATVBAHA.110.207142

Nicholls, 2015, Assessment of the clinical effects of cholesteryl ester transfer protein inhibition with evacetrapib in patients at high-risk for vascular outcomes: rationale and design of the ACCELERATE trial, Am Heart J, 170, 1061, 10.1016/j.ahj.2015.09.007

Nicholls, 2015, Cholesterol efflux capacity and pre-Beta-1 HDL concentrations are increased in Dyslipidemic patients treated with Evacetrapib, J Am Coll Cardiol, 66, 2201, 10.1016/j.jacc.2015.09.013

van Capelleveen, 2016, Effects of the cholesteryl ester transfer protein inhibitor, TA-8995, on cholesterol efflux capacity and high-density lipoprotein particle subclasses, J Clin Lipidol, 10, 1137, 10.1016/j.jacl.2016.06.006

Borggreve, 2008, The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the -629C—>A cholesteryl ester transfer protein promoter polymorphism: role of lecithin: cholesterol acyltransferase activity, Biochim Biophys Acta, 1781, 10, 10.1016/j.bbalip.2007.10.010

McLure, 2013, RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist, PLoS One, 8, 10.1371/journal.pone.0083190

Bailey, 2010, RVX-208: a small molecule that increases apolipoprotein A-I and high-density lipoprotein cholesterol in vitro and in vivo, J Am Coll Cardiol, 55, 2580, 10.1016/j.jacc.2010.02.035

Getz, 2011, A-I mimetic peptides: a role in atherosclerosis, J Inflamm Res, 4, 83, 10.2147/JIR.S12983

Carballo-Jane, 2010, ApoA-I mimetic peptides promote pre-beta HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose, Bioorg Med Chem, 18, 8669, 10.1016/j.bmc.2010.09.074

Liao, 2005, Pleiotropic effects of statins, Annu Rev Pharmacol Toxicol, 45, 89, 10.1146/annurev.pharmtox.45.120403.095748

McTaggart, 2008, Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit, Cardiovasc Drugs Ther, 22, 321, 10.1007/s10557-008-6113-z

Deedwania, 2005, Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome, Am J Cardiol, 95, 360, 10.1016/j.amjcard.2004.09.034

Asztalos, 2002, Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients, Atherosclerosis, 164, 361, 10.1016/S0021-9150(02)00149-1

Asztalos, 2007, Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins, Am J Cardiol, 99, 681, 10.1016/j.amjcard.2006.09.117

Ozerova, 2001, Effects of simvastatin on the phospholipid composition of high-density lipoproteins in patients with hypercholesterolemia, Bull Exp Biol Med, 132, 763, 10.1023/A:1013034029290

Shimizu, 2014, Rosuvastatin activates ATP-binding cassette transporter A1-dependent efflux ex vivo and promotes reverse cholesterol transport in macrophage cells in mice fed a high-fat diet, Arterioscler Thromb Vasc Biol, 34, 2246, 10.1161/ATVBAHA.114.303715

de Vries, 2005, Cellular cholesterol efflux to plasma from moderately hypercholesterolaemic type 1 diabetic patients is enhanced, and is unaffected by simvastatin treatment, Diabetologia, 48, 1105, 10.1007/s00125-005-1760-0

Ronsein, 2016, Niacin therapy increases high-density lipoprotein particles and Total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects, Arterioscler Thromb Vasc Biol, 36, 404, 10.1161/ATVBAHA.115.306268

Wang, 2013, HMG-CoA reductase inhibitors, simvastatin and atorvastatin, downregulate ABCG1-mediated cholesterol efflux in human macrophages, J Cardiovasc Pharmacol, 62, 90, 10.1097/FJC.0b013e3182927e7c

Niesor, 2015, Statin-induced decrease in ATP-binding cassette transporter A1 expression via microRNA33 induction may counteract cholesterol efflux to high-density lipoprotein, Cardiovasc Drugs Ther, 29, 7, 10.1007/s10557-015-6570-0

Franceschini, 2013, Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients, J Clin Lipidol, 7, 414, 10.1016/j.jacl.2013.06.007

Brownell, 2016, Modulating cholesterol efflux capacity to improve cardiovascular disease, Curr Opin Lipidol, 27, 398, 10.1097/MOL.0000000000000317

Tenenbaum, 2012, Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction, Cardiovasc Diabetol, 11, 125, 10.1186/1475-2840-11-125

Triolo, 2014, Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes, Eur J Clin Invest, 44, 240, 10.1111/eci.12226

Gardner, 2000, Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford five City project, Prev Med, 31, 335, 10.1006/pmed.2000.0715

Badeau, 2009, Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17beta-estradiol fatty acyl esters, J Steroid Biochem Mol Biol, 116, 44, 10.1016/j.jsbmb.2009.04.008

Pascot, 2002, HDL particle size: a marker of the gender difference in the metabolic risk profile, Atherosclerosis, 160, 399, 10.1016/S0021-9150(01)00579-2

Catalano, 2008, Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects, J Lipid Res, 49, 635, 10.1194/jlr.M700510-JLR200

Li, 1996, Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes, J Lipid Res, 37, 1886, 10.1016/S0022-2275(20)37553-2

Stevenson, 1993, Influence of age and menopause on serum lipids and lipoproteins in healthy women, Atherosclerosis, 98, 83, 10.1016/0021-9150(93)90225-J

Eapen, 2010, Raising HDL cholesterol in women, Int J Womens Health, 1, 181

Corcoran, 2011, The effect of 17beta-estradiol on cholesterol content in human macrophages is influenced by the lipoprotein milieu, J Mol Endocrinol, 47, 109, 10.1530/JME-10-0158

Badeau, 2013, The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport, Eur J Clin Invest, 43, 317, 10.1111/eci.12044

Badeau, 2007, High-density lipoprotein-associated 17beta-estradiol fatty acyl ester uptake by Fu5AH hepatoma cells: implications of the roles of scavenger receptor class B, type I and the low-density lipoprotein receptor, Biochim Biophys Acta, 1771, 1329, 10.1016/j.bbalip.2007.08.008

El Khoudary, 2016, Cholesterol efflux capacity and subclasses of HDL particles in healthy women transitioning through menopause, J Clin Endocrinol Metab, jc20162144

Pascot, 2001, Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity, J Lipid Res, 42, 2007, 10.1016/S0022-2275(20)31529-7

Williams, 1993, Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses, Arterioscler Thromb, 13, 1654, 10.1161/01.ATV.13.11.1654

Varady, 2011, Comparison of effects of diet versus exercise weight loss regimens on LDL and HDL particle size in obese adults, Lipids Health Dis, 10, 119, 10.1186/1476-511X-10-119

Magkos, 2008, Effect of obesity on the plasma lipoprotein subclass profile in normoglycemic and normolipidemic men and women, Int J Obes (Lond), 32, 1655, 10.1038/ijo.2008.164

Rashid, 2007, Effect of obesity on high-density lipoprotein metabolism, Obesity (Silver Spring), 15, 2875, 10.1038/oby.2007.342

Sasahara, 1997, Altered properties of high density lipoprotein subfractions in obese subjects, J Lipid Res, 38, 600, 10.1016/S0022-2275(20)37268-0

Ding, 2015, Alterations of a cellular cholesterol metabolism network are a molecular feature of obesity-related type 2 diabetes and cardiovascular disease, Diabetes, 64, 3464, 10.2337/db14-1314

Sasahara, 1998, Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects, J Lipid Res, 39, 544, 10.1016/S0022-2275(20)33293-4

Autran, 2001, Basal and postprandial serum-promoted cholesterol efflux in normolipidemic subjects: importance of fat mass distribution, Metabolism, 50, 1330, 10.1053/meta.2001.27206

Attia, 2010, Impact of android overweight or obesity and insulin resistance on basal and postprandial SR-BI and ABCA1-mediated serum cholesterol efflux capacities, Atherosclerosis, 209, 422, 10.1016/j.atherosclerosis.2009.09.025

Mantyselka, 2012, Weight change and lipoprotein particle concentration and particle size: a cohort study with 6.5-year follow-up, Atherosclerosis, 223, 239, 10.1016/j.atherosclerosis.2012.05.005

Asztalos, 2010, Effects of weight loss, induced by gastric bypass surgery, on HDL remodeling in obese women, J Lipid Res, 51, 2405, 10.1194/jlr.P900015-JLR200

Aron-Wisnewsky, 2011, Effect of bariatric surgery-induced weight loss on SR-BI-, ABCG1-, and ABCA1-mediated cellular cholesterol efflux in obese women, J Clin Endocrinol Metab, 96, 1151, 10.1210/jc.2010-2378

Davidson, 2017, Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function, Int J Obes (Lond), 41, 83, 10.1038/ijo.2016.190

Osto, 2015, Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1, Circulation, 131, 871, 10.1161/CIRCULATIONAHA.114.011791

Wang, 2011, Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL, Diabetes Care, 34, 2576, 10.2337/dc11-0685

Aicher, 2012, Diet-induced weight loss in overweight or obese women and changes in high-density lipoprotein levels and function, Obesity (Silver Spring), 20, 2057, 10.1038/oby.2012.56

Vasudevan, 2013, Modest diet-induced weight loss reduces macrophage cholesterol efflux to plasma of patients with metabolic syndrome, J Clin Lipidol, 7, 661, 10.1016/j.jacl.2013.05.004

Martinez-Ramirez, 2016, HDL-sphingomyelin reduction after weight loss by an energy-restricted diet is associated with the improvement of lipid profile, blood pressure, and decrease of insulin resistance in overweight/obese patients, Clin Chim Acta, 454, 77, 10.1016/j.cca.2015.12.039

North, 2012, The intersection between aging and cardiovascular disease, Circ Res, 110, 1097, 10.1161/CIRCRESAHA.111.246876

Walter, 2009, Interrelationships among HDL metabolism, aging, and atherosclerosis, Arterioscler Thromb Vasc Biol, 29, 1244, 10.1161/ATVBAHA.108.181438

Luc, 1991, High-density lipoprotein particles in octogenarians, Metabolism, 40, 1238, 10.1016/0026-0495(91)90022-O

Mutharasan, 2017, HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago healthy aging study, J Lipid Res, 58, 600, 10.1194/jlr.P069039

Suc, 2003, Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B, J Cell Sci, 116, 89, 10.1242/jcs.00126

Berrougui, 2007, Age-related impairment of HDL-mediated cholesterol efflux, J Lipid Res, 48, 328, 10.1194/jlr.M600167-JLR200

Khalil, 1998, Age-related increased susceptibility of high-density lipoproteins (HDL) to in vitro oxidation induced by gamma-radiolysis of water, FEBS Lett, 435, 153, 10.1016/S0014-5793(98)01058-8

Sene, 2013, Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration, Cell Metab, 17, 549, 10.1016/j.cmet.2013.03.009

Rayner, 2010, MiR-33 contributes to the regulation of cholesterol homeostasis, Science, 328, 1570, 10.1126/science.1189862

Annema, 2012, ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma, J Lipid Res, 53, 929, 10.1194/jlr.M020743

Holzer, 2013, Aging affects high-density lipoprotein composition and function, Biochim Biophys Acta, 1831, 1442, 10.1016/j.bbalip.2013.06.004

Hoang, 2008, ABCA1 expression in humans is associated with physical activity and alcohol consumption, Atherosclerosis, 197, 197, 10.1016/j.atherosclerosis.2007.03.017

Olchawa, 2004, Physical fitness and reverse cholesterol transport, Arterioscler Thromb Vasc Biol, 24, 1087, 10.1161/01.ATV.0000128124.72935.0f

Escola-Gil, 2015, HDL and lifestyle interventions, Handb Exp Pharmacol, 224, 569, 10.1007/978-3-319-09665-0_18

Freeman, 1993, Smoking and plasma lipoproteins in man: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution, Eur J Clin Invest, 23, 630, 10.1111/j.1365-2362.1993.tb00724.x

Song, 2015, The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients, J Lipid Res, 56, 682, 10.1194/jlr.P055491

Beulens, 2004, Moderate alcohol consumption increases cholesterol efflux mediated by ABCA1, J Lipid Res, 45, 1716, 10.1194/jlr.M400109-JLR200

Syeda, 2003, Postprandial variations in the cholesteryl ester transfer protein activity, phospholipid transfer protein activity and plasma cholesterol efflux capacity in normolipidemic men, Nutr Metab Cardiovasc Dis, 13, 28, 10.1016/S0939-4753(03)80165-5

Berryman, 2013, Acute consumption of walnuts and walnut components differentially affect postprandial lipemia, endothelial function, oxidative stress, and cholesterol efflux in humans with mild hypercholesterolemia, J Nutr, 143, 788, 10.3945/jn.112.170993

Bechor, 2016, 9-cis beta-carotene increased cholesterol efflux to HDL in macrophages, Nutr, 8

Afonso Mda, 2014, The impact of dietary fatty acids on macrophage cholesterol homeostasis, J Nutr Biochem, 25, 95, 10.1016/j.jnutbio.2013.10.001

Buonacorso, 2007, Macrophage cholesterol efflux elicited by human total plasma and by HDL subfractions is not affected by different types of dietary fatty acids, Am J Clin Nutr, 86, 1270, 10.1093/ajcn/86.5.1270

Kralova Lesna, 2008, Replacement of dietary saturated FAs by PUFAs in diet and reverse cholesterol transport, J Lipid Res, 49, 2414, 10.1194/jlr.M800271-JLR200

Wang, 2002, Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1, J Biol Chem, 277, 5692, 10.1074/jbc.M109977200

Kasbi Chadli, 2013, Omega 3 fatty acids promote macrophage reverse cholesterol transport in hamster fed high fat diet, PLoS One, 8, 10.1371/journal.pone.0061109

Tanaka, 2014, Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia, Atherosclerosis, 237, 577, 10.1016/j.atherosclerosis.2014.10.011

Ringseis, 2008, Conjugated linoleic acid isomers reduce cholesterol accumulation in acetylated LDL-induced mouse RAW264.7 macrophage-derived foam cells, Lipids, 43, 913, 10.1007/s11745-008-3226-x

Helal, 2013, Extra-virgin olive oil consumption improves the capacity of HDL to mediate cholesterol efflux and increases ABCA1 and ABCG1 expression in human macrophages, Br J Nutr, 109, 1844, 10.1017/S0007114512003856

Farras, 2013, Olive oil polyphenols enhance the expression of cholesterol efflux related genes in vivo in humans. A randomized controlled trial, J Nutr Biochem, 24, 1334, 10.1016/j.jnutbio.2012.10.008

Hernaez, 2014, Olive oil polyphenols enhance high-density lipoprotein function in humans: a randomized controlled trial, Arterioscler Thromb Vasc Biol, 34, 2115, 10.1161/ATVBAHA.114.303374

Hernaez, 2017, Mediterranean diet improves high-density lipoprotein function in high-cardiovascular-risk individuals: a randomized controlled trial, Circulation, 135, 633, 10.1161/CIRCULATIONAHA.116.023712

Villard, 2013, Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels, Arterioscler Thromb Vasc Biol, 33, 822, 10.1161/ATVBAHA.112.300979

Koekemoer, 2017, Large-scale analysis of determinants, stability, and heritability of high-density lipoprotein cholesterol efflux capacity, Arterioscler Thromb Vasc Biol, 37, 1956, 10.1161/ATVBAHA.117.309201

Ronsein, 2017, Inflammation, remodeling, and other factors affecting HDL cholesterol efflux, Curr Opin Lipidol, 28, 52, 10.1097/MOL.0000000000000382

Tall, 2015, Cholesterol, inflammation and innate immunity, Nat Rev Immunol, 15, 104, 10.1038/nri3793

Eren, 2012, High density lipoprotein and it's dysfunction, Open Biochem J, 6, 78, 10.2174/1874091X01206010078

Vaisar, 2015, Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity, J Lipid Res, 56, 1519, 10.1194/jlr.M059089

McGillicuddy, 2009, Inflammation impairs reverse cholesterol transport in vivo, Circulation, 119, 1135, 10.1161/CIRCULATIONAHA.108.810721

de Beer, 2011, ATP binding cassette G1-dependent cholesterol efflux during inflammation, J Lipid Res, 52, 345, 10.1194/jlr.M012328

Wang, 2010, Inflammation, a link between obesity and cardiovascular disease, Mediators Inflamm, 2010, 535918, 10.1155/2010/535918

Voloshyna, I. and S. Seshadri, Infliximab reverses suppression of cholesterol efflux proteins by TNF-alpha: a possible mechanism for modulation of atherogenesis. 2014. 2014: p. 312647.

Petelin, 2014, Low-grade inflammation in overweight and obese adults is affected by weight loss program, J Endocrinol Invest, 37, 745, 10.1007/s40618-014-0102-9

Rohatgi, 2014, HDL cholesterol efflux capacity and incident cardiovascular events, N Engl J Med, 371, 2383, 10.1056/NEJMoa1409065

Ishikawa, 2015, High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease, Atherosclerosis, 242, 318, 10.1016/j.atherosclerosis.2015.06.028